ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
70,180.77
-1.78%
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs Yen
156.184
-0.12%
Brent Oil
82.445
-1.30%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Rhythm Pharmaceuticals Inc (RYTM)

  7. Rhythm Pharmaceuticals Inc (RYTM) ニュース

RYTM

Rhythm Pharmaceuticals (RYTM)

Rhythm Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:RYTM
日付受信時刻ニュースソース見出しコード企業名
2024/05/1405 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/05/1005 : 17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/05/1005 : 01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/05/0805 : 43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/05/0720 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/05/0720 : 00GlobeNewswire Inc.Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business UpdateNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/05/0621 : 00GlobeNewswire Inc.Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual MeetingNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/04/3007 : 30GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & EndocrinologyNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/04/2505 : 01GlobeNewswire Inc.Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/04/1705 : 01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/04/0121 : 00GlobeNewswire Inc.Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock FinancingNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/03/2521 : 00GlobeNewswire Inc.Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific AgonistNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/03/1205 : 01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/03/0706 : 01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation at Upcoming Investor ConferencesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/03/0106 : 58Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/03/0106 : 46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/03/0106 : 44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/03/0106 : 05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/2221 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/2221 : 01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in JapanNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/2221 : 00GlobeNewswire Inc.Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business UpdateNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/2209 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/2209 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/2209 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/2209 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/1608 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/1410 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/1410 : 47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/1410 : 46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
2024/02/1410 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RYTM

最近閲覧した銘柄

FX
USDEUR
US Dollar vs Euro
FX
USDGBP
US Dollar vs Sterling
COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
NASDAQ
NVDA
NVIDIA
NASDAQ
AMZN
Amazon.com
NYSE
AXP
American Express
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
USOTC
RHHBY
Roche (QX)
SPI
SP500
S&P 500
FX
USDJPY
US Dollar vs Yen
USOTC
BNPQY
BNP Paribas (QX)
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有